RESEARCH AND DEVELOPMENT
Research and Development
| Therapeutic Area | Project Code | Target | Indications | Nonclinical | Pre-IND | IND | Phase I | Phase II | Phase III | NDA |
Tumor 
|
HB0025 | PD-L1/VEGF | Solid tumors | |||||||
| HB0052 | CD73-ADC | Solid tumors | ||||||||
Autoimmune 
|
HB0017 | IL-17A | Moderate,severe plaque psoriasis / Psoriatic arthritis Ankylosing spondylitis | |||||||
| HB0034 | IL-36R | Pustular psoriasis Systemic lupus erythematosus Ulcerative colitis | ||||||||
| HB0056 | TSLP/IL-11 | Asthma / AD /IPF /COPD | ||||||||
| HB0043 | IL-17A/IL-36R | HS /LN /CKD /AD | ||||||||